Blood biomarkers for Alzheimer's disease are correlated with measures of agitation and cognition in a randomized trial assessing the effects of escitalopram on agitation

ABSTRACT:

SUBMITTER: Barnwal M 

PROVIDER: S-EPMC12812854 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature